Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial - Authors' reply.
Saved in:
| Title: | Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial - Authors' reply. |
|---|---|
| Authors: | Chow PKH; Division of Surgery and Surgical Oncology, National Cancer Centre Singapore and Duke-NUS Medical School, Singapore; Program in Translational and Liver Cancer Research, National Cancer Centre Singapore, Singapore 168583. Electronic address: pierce.chow@duke-nus.edu.sg., Hack SP; Genentech, San Francisco, CA, USA., Spahn JH; Genentech, San Francisco, CA, USA., Yopp AC; Department of Surgery, Division of Surgical Oncology, The University of Texas Southwestern Medical Center, Dallas, TX, USA. |
| Source: | Lancet (London, England) [Lancet] 2024 Aug 17; Vol. 404 (10453), pp. 657-658. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
